Description

Active ingredient:

Glipizide 5mg

Indication:

Glipizide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Direction:

As for any hypoglycemic agent, dosage must be adapted for each individual case.The recommended starting dose is 5 mg day, given before breakfast or the mid-day meal. Elderly patients and other patients at risk for hypoglycemia may be started on 2.5 mg. 

Precaution:

You should not use Minidiab if you:

allergic to glipizide or any other sulphonylurea or any ingredients in Minidiab tablets

pregnant may become pregnant or breast-feeding – have type I diabetes mellitus (insulin dependent diabetes mellitus), diabetic ketoacidosis, or diabetic coma – have severe kidney, liver or thyroid disease

Side effects:

nausea, vomiting, stomach pain, diarrhea, constipation.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.